Scott Henry
Stock Analyst at Alliance Global Partners
(2.01)
# 1,771
Out of 4,412 analysts
44
Total ratings
36.73%
Success rate
-6.21%
Average return
Main Sectors:
23 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DERM Journey Medical | Initiates: Buy | $8.5 | $3.40 | +150.00% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $1.24 | +221.80% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $1.72 | +772.09% | 1 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $2.99 | +301.34% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $5.02 | +49.40% | 1 | Sep 22, 2023 | |
| DCTH Delcath Systems | Maintains: Buy | $10 → $13 | $5.30 | +145.28% | 3 | Aug 16, 2023 | |
| VKTX Viking Therapeutics | Maintains: Buy | $19 → $24 | $74.31 | -67.70% | 2 | May 3, 2023 | |
| IONM Assure Holdings | Maintains: Buy | $60 → $12 | $0.70 | +1,624.14% | 2 | Apr 12, 2023 | |
| LGND Ligand Pharmaceuticals | Maintains: Buy | $85 → $90 | $70.57 | +27.53% | 7 | Dec 23, 2022 | |
| CPRX Catalyst Pharmaceuticals | Downgrades: Neutral | $10 → $16 | $14.89 | +4.10% | 2 | Aug 24, 2022 | |
| INVO INVO Bioscience | Downgrades: Neutral | $40 | $0.98 | +3,981.63% | 2 | Apr 13, 2022 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $275 → $250 | $2.59 | +9,552.51% | 3 | Aug 13, 2021 | |
| LMAT LeMaitre Vascular | Maintains: Neutral | n/a | $65.46 | - | 1 | Aug 3, 2021 | |
| IRMD IRadimed | Maintains: Buy | n/a | $41.86 | - | 1 | Aug 2, 2021 | |
| IRIX IRIDEX | Maintains: Buy | n/a | $2.87 | - | 2 | Mar 3, 2021 | |
| SRTS Sensus Healthcare | Maintains: Buy | n/a | $3.41 | - | 1 | Feb 26, 2021 | |
| INM InMed Pharmaceuticals | Maintains: Buy | n/a | $0.23 | - | 1 | Feb 16, 2021 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $0.79 | - | 1 | Dec 4, 2020 | |
| MYO Myomo | Upgrades: Buy | n/a | $3.43 | - | 1 | Nov 11, 2020 | |
| TNXP Tonix Pharmaceuticals Holding | Upgrades: Buy | n/a | $0.17 | - | 3 | Apr 18, 2019 | |
| QBIO Q BioMed | Downgrades: Neutral | n/a | $0.00 | - | 1 | Nov 29, 2018 | |
| NBY NovaBay Pharmaceuticals | Downgrades: Neutral | n/a | $0.08 | - | 1 | Mar 26, 2018 | |
| TTNP Titan Pharmaceuticals | Downgrades: Neutral | n/a | $7.09 | - | 1 | Nov 10, 2017 |
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $3.40
Upside: +150.00%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $1.24
Upside: +221.80%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $1.72
Upside: +772.09%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $2.99
Upside: +301.34%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $5.02
Upside: +49.40%
Delcath Systems
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $5.30
Upside: +145.28%
Viking Therapeutics
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $74.31
Upside: -67.70%
Assure Holdings
Apr 12, 2023
Maintains: Buy
Price Target: $60 → $12
Current: $0.70
Upside: +1,624.14%
Ligand Pharmaceuticals
Dec 23, 2022
Maintains: Buy
Price Target: $85 → $90
Current: $70.57
Upside: +27.53%
Catalyst Pharmaceuticals
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $14.89
Upside: +4.10%
INVO Bioscience
Apr 13, 2022
Downgrades: Neutral
Price Target: $40
Current: $0.98
Upside: +3,981.63%
Vivos Therapeutics
Aug 13, 2021
Maintains: Buy
Price Target: $275 → $250
Current: $2.59
Upside: +9,552.51%
LeMaitre Vascular
Aug 3, 2021
Maintains: Neutral
Price Target: n/a
Current: $65.46
Upside: -
IRadimed
Aug 2, 2021
Maintains: Buy
Price Target: n/a
Current: $41.86
Upside: -
IRIDEX
Mar 3, 2021
Maintains: Buy
Price Target: n/a
Current: $2.87
Upside: -
Sensus Healthcare
Feb 26, 2021
Maintains: Buy
Price Target: n/a
Current: $3.41
Upside: -
InMed Pharmaceuticals
Feb 16, 2021
Maintains: Buy
Price Target: n/a
Current: $0.23
Upside: -
Bionano Genomics
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.79
Upside: -
Myomo
Nov 11, 2020
Upgrades: Buy
Price Target: n/a
Current: $3.43
Upside: -
Tonix Pharmaceuticals Holding
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $0.17
Upside: -
Q BioMed
Nov 29, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.00
Upside: -
NovaBay Pharmaceuticals
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.08
Upside: -
Titan Pharmaceuticals
Nov 10, 2017
Downgrades: Neutral
Price Target: n/a
Current: $7.09
Upside: -